Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology

Hepato-Gastroenterology

Volumn 55, Issue 86-87, 2008, Pages 1939-1942

  Ako, Eiji ^a   Ohira, Masaichi ^a   Yamashita, Yoshito ^a   Kubo, Naoshi ^a   Muguruma, Kazuya ^a   Yashiro, Masakazu ^a   Sawada, Tetsuji ^a   Nakata, Bunzo ^a   Kato, Yasuyuki ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Peritoneal lavage cytology; Postoperative chemotherapy; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; DOXIFLURIDINE; FLUOROURACIL; MITOMYCIN C; TEGAFUR; UFT;

ADULT; AGED; ANEMIA; ARTICLE; ASCITES FLUID CYTOLOGY; BLOOD TOXICITY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTRECTOMY; HAND FOOT SYNDROME; HUMAN; HYPERBILIRUBINEMIA; LABORATORY TEST; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; PERITONEUM LAVAGE; PIGMENT DISORDER; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMATITIS; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT DURATION; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG COMBINATIONS; FEMALE; HUMANS; IRRIGATION; MALE; MIDDLE AGED; OXONIC ACID; PERITONEAL NEOPLASMS; PERITONEUM; STOMACH NEOPLASMS; TEGAFUR;

EID: 57049126550     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ: Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 1993; 80:1015-1018.
2. Allum, WH, Powell DJ, McConkey CC, Fielding JW: Gastric cancer: a 25-year review. Br J Surg 1989; 76:535-540.
3. Suzuki T, Ochiai T, Hayashi H, Hori S, Shimada H, Isono K: Peritoneal lavage cytology findings as prognostic factor for gastric cancer. Semin Surg Oncol 1999; 17:103-107.
4. Suzuki T, Ochiai T, Hayashi H, Nakajima K, Yasumoto A, Hishikawa E, Shimada H, Horiuchi F, Ohki S, Isono K: Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer. Surg Today 1999; 29:111-115.
5. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998; 1:10-24.
6. Yamagata S, Nakata B, Hirakawa K: Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer. Oncol Rep 2004; 12:973-978.
7. Sakata Y, Ohtsu A, Horikoshi N, Sugimachi K, Mitachi Y, Taguchi T: Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 1998; 34:1715-1720.
8. Koizumi W, Kurihara M, Nakano S, Hasegawa K: Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology 2000; 58:191-197.
9. Maehara Y, Okuyama T, Kakeji Y, Baba H, Furusawa M, Sugimachi K: Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. Am J Surg 1994; 168:36-40.
10. Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ: Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 1996; 83:672-674.
11. Wu CC, Chen JT, Chang MC, Ho WL, Chen CY, Yeh DC, Liu TJ, P'eng FK: Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells. J Am Coll Surg 1997; 184:611-617.
12. Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K, Yamamoto M: Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990; 77:436-439.
13. Sugimachi K, Maehara Y, Horikoshi N, Shimada Y, Sakata Y, Mitachi Y, Taguchi T: An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group. Oncology 1999; 57:202-210.